Author Question: _________ is a drug developed specifically for the treatment of smoking and works by competing with ... (Read 104 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
_________ is a drug developed specifically for the treatment of smoking and works by competing with nicotine in binding to nicotine receptors in the brain.
 
  a. Varenicline
  b. Bupropion
  c. Fluoxetine
  d. Nicorette

Question 2

Research on the use of nicotine replacement therapies leads to the conclusion that _________.
 
  a. there are no demonstrable differences in effectiveness between different nicotine replacement therapies
  b. they are only slightly more effective than placebos
  c. there may be significant long-term consequences to their use
  d. pairing them with behavioral therapies does little to enhance treatment effectiveness



Laurenleakan

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

a

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library